National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
Quit Smoking Today
NCI Highlights
Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

The Nation's Investment in Cancer Research FY 2009

Past Highlights
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

monoclonal antibody A33
A humanized monoclonal antibody directed against the human A33 antigen. Monoclonal antibody A33 recognizes the human A33 antigen, a 43 KDa transmembrane glycoprotein of the immunoglobulin superfamily, which is highly and homogenously expressed in 95% of colorectal cancer metastases with only restricted expression in normal colonic mucosa. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:A33
A33 monoclonal antibody
Abbreviation:MOAB A33



Previous:monoclonal antibody 11D10 anti-idiotype vaccine, monoclonal antibody 14G2A, monoclonal antibody 3F8, monoclonal antibody 3H1 anti-idiotype vaccine, monoclonal antibody A27.15
Next:monoclonal antibody CAL, monoclonal antibody CC49, monoclonal antibody CC49-delta CH2, monoclonal antibody Ch14.18, monoclonal antibody E2.3

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov